首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
【24h】

Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.

机译:大肠杆菌O157溶血性尿毒症综合征后5年的蛋白尿和估计GFR:更新。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Knowledge of the long-term prognosis of patients with diarrhea-associated hemolytic uremic syndrome (HUS) is important for patient counseling and follow-up. Estimates in the literature are highly variable, and previous studies did not use a healthy control group to establish outcomes attributable to HUS. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 19 children who recovered from HUS after contamination of their municipal water supply by Escherichia coli O157:H7. PREDICTOR: Outcomes of children who recovered from HUS were compared with a control group of 64 children who were healthy at the time of the outbreak. Both groups were similar in their demographics and follow-up testing. OUTCOMES & MEASUREMENTS: Proteinuria, blood pressure, glomerular filtration rate (GFR) estimated by using serum creatinine or cystatin C level, and biochemical measures 5 years after the outbreak. RESULTS: More children who recovered from HUS showed microalbuminuria than controls (20% versus 3%; relative risk, 6.0; 95% confidence interval, 1.1 to 32.8). There were no differences between groups in blood pressure or GFR when estimated by using serum creatinine level. GFR estimated by using cystatin C level was lower after HUS compared with controls (100 versus 110 mL/min/1.73 m(2); P = 0.02), but no child had a GFR less than 80 mL/min/1.73 m(2). Other results, including fasting glucose, albumin, and C-reactive protein levels, did not differ between groups. LIMITATIONS: Although the homogenous nature of this outbreak is a strength, long-term results may generalize less well to patients with other strains of toxigenic E coli or in other settings. CONCLUSIONS: The prognosis of patients with HUS in this cohort was better than in other studies. Ongoing follow-up will clarify the clinical relevance of microalbuminuria and mild decreases in GFR 5 years after HUS recovery.
机译:背景:腹泻相关溶血性尿毒症综合征(HUS)患者的长期预后知识对患者咨询和随访很重要。文献中的估计值变化很大,以前的研究没有使用健康的对照组来确定归因于HUS的结果。研究设计:前瞻性队列研究。地点和参加者:19名儿童因大肠杆菌O157:H7污染了市政供水而从HUS中康复。预测:将HUS康复儿童的结局与爆发时健康的对照组64名儿童进行了比较。两组的人口统计学和后续测试相似。结果与测量:爆发后5年,通过血清肌酐或半胱氨酸蛋白酶抑制剂C水平估算蛋白尿,血压,肾小球滤过率(GFR)以及生化指标。结果:从HUS康复的儿童比对照组有更多的儿童出现微量白蛋白尿(20%比3%;相对风险6.0; 95%置信区间1.1至32.8)。使用血清肌酐水平评估时,两组之间的血压或GFR无差异。 HUS后使用胱抑素C水平估算的GFR低于对照组(100 vs 110 mL / min / 1.73 m(2); P = 0.02),但是没有儿童的GFR低于80 mL / min / 1.73 m(2) )。两组之间的其他结果(包括空腹血糖,白蛋白和C反应蛋白水平)没有差异。局限性:尽管这种暴发的同质性是一种优势,但长期结果可能会不适用于其他产毒大肠埃希菌菌株或处于其他环境的患者。结论:该队列研究的HUS患者的预后好于其他研究。持续的随访将阐明HUS康复5年后微量蛋白尿的临床相关性和GFR的轻度下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号